Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Biological Chemistry|April 17, 1999
Mutation of tyrosine 960 within the insulin receptor juxtamembrane domain impairs glucose transport but does not inhibit ligand-mediated phosphorylation of insulin receptor substrate-2 in 3T3-L1 adipocytesO V Chaika, N Chaika, D J Volle, et al.
Oncogene|July 1, 1991
Oncogenic potential of erbB-2 in human mammary epithelial cellsJ H Pierce, P Arnstein, E DiMarco, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1993
Inhibition of platelet-derived growth factor autocrine growth stimulation by a monoclonal antibody to the human alpha platelet-derived growth factor receptorW J LaRochelle, R A Jensen, M A Heidaran, et al.
The Journal of Biological Chemistry|January 10, 1997
Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cellsM J Welham, H Bone, M Levings, et al.
Molecular and Cellular Biology|June 1, 1994
Role of IRS-1-GRB-2 complexes in insulin signalingM G Myers, L M Wang, X J Sun, et al.
International Immunology|August 1, 1992
The expression of the mouse VpreB/lambda 5 locus in transformed cell lines and tumors of the B lineage differentiation pathwayA Kudo, P Thalmann, N Sakaguchi, et al.
Molecular and Cellular Biology|June 1, 1991
The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transductionO Segatto, F Lonardo, D Wexler, et al.
Cancer Research|August 12, 1998
ErbB-4 ribozymes abolish neuregulin-induced mitogenesisC K Tang, D J Goldstein, J Payne, et al.
The Journal of Cell Biology|April 1, 1995
Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimeraW J LaRochelle, O R Dirsch, P W Finch, et al.
Radiation Research|April 1, 1990
Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rateT J FitzGerald, S Henault, M Sakakeeny, et al.
Pageof 14